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Abstract: Efficient preparation and labeling of human induced pluripotent stem (iPS) cells 
is a great challenge in stem cell research and development. With the aim of investigating the 
feasibility of using nanotechnology to enhance the preparation efficiency of iPS cells and to 
label iPS cells for long-term tracing and imaging, in this paper, four transcription factor genes, 
ie, Oct4, Sox2, LIN28, and Nanog, and packaging plasmids such as PSPAX2 and PMD2.G 
were cotransfected into 293T cells using Generation 5.0 polyamidoamine dendrimer-modified 
magnetic nanoparticles (dMNPs) as a delivery system. The resultant supernatant liquids were 
incubated with human fibroblast cells at 37°C for 21 days, then the embryonic stem (ES)   cell-like 
clones were screened, cultured, and identified. Finally, the prepared iPS cells were labeled with 
fluorescent magnetic nanoparticles (FMNPs). The results showed that dMNPs can efficiently 
deliver all vectors into 293T cells. The resultant lentiviruses’ titers were 10-fold more than 
those based on Lipofectamine™ 2000. Reverse transcription polymerase chain reaction   analysis 
showed that four genes (Oct4, Sox2, LIN28, and Nanog) exhibited different expressions in 
iPS cells. Immunostaining analysis showed that specific surface markers of ES cells such as 
SSEA-3, SSEA-4, Tra-1-60, and Tra-1-81 were positive in iPS cells, and the terotomas were 
formed in NOD-SCID mice that were implanted with iPS cells. Red fluorescent signals could be 
observed in iPS cells labeled with FMNPs by fluorescent microscopy, and the magnetic signals 
were detected in labeled iPS cells by magnetic resonance imaging. In conclusion, human iPS 
cells can be efficiently generated using polyamidoamine dMNPs and lentivirus and labeled 
with FMNPs for long-term observation and tracking, which has great potential application in 
the research and development of stem cells in the near future.
Keywords: induced pluripotent stem cells, polyamidoamine dendrimer-modified magnetic 
nanoparticles, fluorescent magnetic nanoparticle, preparation, label
Introduction
Since induced pluripotent stem (iPS) cells were first successfully generated from mouse 
embryonic fibroblasts (MEFs),1 iPS cell research and development has become a hot 
topic. Mice have been cloned from iPS cells,2 and stem cells have been labeled with 
fluorescent dyes such as NIR815 and ICG.3,4 Although iPS cells offer great progress for 
controllable manmade stem cells, several obstacles seriously affect the further research 
and development of iPS cells, including the development of advanced techniques to 
enhance the efficiency of iPS cell preparation and novel methods to label and track 
transplanted stem cells for long-term observation, as well as new nonvirus vectors to 
replace lentivirus vectors to enhance their safety. To date, the techniques of preparing 
iPS cells efficiently have not achieved a big breakthrough. How to fabricate many iPS International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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cells within a limited timeframe has become a challenging 
problem. How to label iPS cells for long-term observation 
is another challenge.
In recent years, stem cell nanotechnology has emerged 
as a new, exciting field.5 The importance of nanomaterials, 
nanostructures, and nanotechnology to the fundamental 
developments in stem cell-based therapies for injuries 
and degenerative diseases has been recognized.6–10 It is 
well known that nanomaterials have some unique effects. 
Ultimately, these effects can lead to new technological 
opportunities as well as new challenges.11–13 The application 
of nanotechnology in stem cell research and development 
has attractive technological prospects, which provide a 
new opportunity to solve current problems facing stem cell 
research and development. However, so far, few reports are 
closely associated with the use of nanotechnology to enhance 
the preparation efficiency of human iPS cells and labeling iPS 
cells for long-term tracking of their in vivo distribution and 
metabolism course. In our previous studies, we confirmed that 
polyamidoamine (PAMAM) dendrimer-modified magnetic 
nanopaticles (dMNPs) were one example of a highly efficient 
gene delivery system.14–16 Fluorescent magnetic nanoparticles 
(FMNPs) can be used as dual-modality imaging contrast 
reagents for long-term observation of tumor cells.17–19
In this study, we used PAMAM dMNPs and FMNPs, 
prepared human iPS cells by using Generation 5.0 (G5.0) 
PAMAM dMNPs and lentivirus vectors, and labeled iPS 
cells with FMNPs for long-term observation and tracking. 
Our aim was to investigate the feasibility of using PAMAM 
dMNPs to enhance the efficiency of preparing lentivirus with 
four genes and laying the foundations for further   studies on 
iPS cell distribution, imaging, and tracking in vivo by using 
FMNPs. Our results show that PAMAM dMNPs could 
markedly increase the titer of lentivirus in supernatant   liquids 
of 293T cells. The iPS cells can be successfully generated 
from human fibroblast cells transducted with prepared 
  lentivirus and labeled with FMNPs, which has great potential 
application in long-term tracking and functional research into 
human iPS cells in vivo.
Materials and methods
cell culture
Human dermal fibroblast (HDF) cells were primary cultured. 
293T cells and MEF cells were provided by the Shanghai 
Institute of Digestive Diseases, Renji Hospital, Shanghai 
Second Medical University, Shanghai, People’s Republic 
of China. HDF, 293T, and MEF cells were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM, GIBCO®) 
containing 10% fetal bovine serum (FBS, GIBCO) and 1.0% 
penicillin and streptomycin (GIBCO). iPS cells were gener-
ated and maintained in a human embryonic stem (ES) cell 
medium, which was made up with F12/DMEM (GIBCO) 
supplemented with Knockout SR® (GIBCO), basic fibro-
blast growth factor (Invitrogen), nonessential amino acids 
(GIBCO), L-glutamine (GIBCO), and β-mercaptoethanol 
(GIBCO). iPS cells were cultured on MEF feeder cell dishes, 
which were coated with BD Matrigel™ in advance according 
to the standard human ES cell culture protocol.20
Plasmid construction
Packaging plasmid psPAX2, enveloping plasmid pMD2.G, 
and four transcription factors pSin-EF2-Oct4-Pur, 
pSin-EF2-Sox2-Pur, pSin-EF2-LIN28-Pur, and pSin-
EF2-Nanog-Pur were purchased from Addgene Inc., 
Cambridge, MA, USA (Cat No. 12260, 12259, 16579, 
16577, 16580, and 16578). We extracted the plasmids 
from the bacteria by QIAGEN® Maxi Kit according to the 
manufacturer’s   protocol. These plasmids were identified 
by enzyme   digestion.   According to the plasmid maps, we 
chose EcoRV (TaKaRa) and SacI (TaKaRa) as restriction 
enzymes of psPAX2, NotI (TaKaRa) and HindIII (TaKaRa) 
as   restriction enzymes of PMD2.G, and EcoRI (TaKaRa) 
and SpeI (TaKaRa) as   restriction enzymes of Oct4, Sox2, 
Nanog, and LIN28.
Preparation and characterization  
of dMNPs
MNPs were prepared by coprecipitation of Fe2+ and Fe3+ in 
the presence of NaOH,21,22 and were dispersed in phosphate 
buffered saline (PBS) (pH 7.4). G5.0 PAMAM dMNPs 
were prepared according to our previous reports.23,24 
Generation 0 (G0) dMNP represents the MNPs modified 
with only 3-aminopropyltrimethoxysilane (NH2(CH2)3-
Si-(OCH3)3). Dendrimer generation was initiated with 
G0 methanol solution. Stepwise growth using methacrylate 
and   ethylenediamine was repeated until the desired number 
of generations from 1.0 to 5.0 (G1.0–G5.0) was achieved. 
To characterize the samples, portions of the G5.0 PAMAM 
dMNP suspensions were dried at 80°C under vacuum. The 
average size was estimated using a transmission electron 
microscope (TEM, JEOL, JEM2010, Japan). Fourier 
transform infrared (FT-IR) spectra of suspensions were 
obtained using an FT-IR spectrophotometer (AVATAR 
360, Nicolet, USA).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Transfection plasmid and lentivirus 
production
293T cells were plated in 100 mm dishes at 80% confluence 
and were transfected with plasmids using dMNPs. Respec-
tively, different plasmids (Oct4, Sox2, LIN28, Nanog, 
PSPAX2, and PMD2.G) were mixed with dMNPs in DMEM 
without FBS and incubated for 30 minutes at room temperature 
under the condition of 10:1 of the charge ratio of dMNPs and 
plasmids complex (the mass ratio is 4:3:2 of transcription 
factor, PSPAX2, and PMD2.G). 293T cells were transfected 
with medium without serum by the addition of four kinds of 
dMNPs–plasmids complex (Oct4, Sox2, LIN28, Nanog), 
respectively. We changed the fresh medium after transfection 
for 4 hours. Then, the four kinds of supernatant of medium 
(Oct4, Sox2, LIN28, Nanog) were collected after transfection 
for 48 hours, respectively. Supernatants were filtered through 
0.45 µm pore size   cellulose acetate filters (Millipore, Billerica, 
MA, USA) and centrifuged at 23,000 rpm for 90 minutes at 
4°C. The viral pellets were resuspended in DMEM to obtain a 
10,000-fold concentration. Viral stocks were stored at -80°C 
until transduction. Viral titers were measured according to 
the protocol of the   QuickTiter™ Lentivirus Quantitation Kit 
(Cell Biolabs, San Diego, CA, USA) and were determined 
by infection of 293T cells.   Lipofectamine 2000 was used as 
a control transfection reagent.
Lentivirus transduction  
and reprogramming culture
HDF cells were plated in a 10 cm dish at 80%   confluence before 
transduction. We prepared a medium with 10% FBS by the 
addition of virus solution, which mixed an equal volume of 
concentrated virus solution, such as Oct4, Sox2, LIN28, and 
Nanog (according to 10:1 of the number ratio of virus and cells), 
then we transducted the medium   supplemented with 10 µg/mL 
polybrene into HDF cells and co-culture overnight at 37°C in 
a humidified 5% CO2 incubator. We used fresh medium every 
day for the first 3 days and a human ES cell medium every day 
for the   following days. Twenty-one days after transduction, 
some colonies emerged. The colonies’ morphology was similar 
to that of human ES cells. We extracted colonies into an MEF 
feeder and cultured the iPS cells according to the standard 
human ES cell culture protocol.20
Reverse transcription-polymerase  
chain reaction (RT-PcR)
PCR primers were designed and synthesized. The concrete 
sequences were as follows:
Oct4-forward 5′-CAGTGCCCGAAACCCACAC-3′
Oct4-reverse 5′-GGAGACCCAGCAGCCTCAAA-3′
Sox2-forward 5′-AGCTACAGCATGATGCAGGA-3′
Sox2-reverse 5′-GGTCATGGAGTTGTACTGCA-3′
Nanog-forward 5′-CAGAAGGCCTCAGCACCTAC-3′
Nanog-reverse 5′-ATTGTTCCAGGTCTGGTTGC-3′
LIN28-forward 5′-TGCGGGCATCTGTAAGTGG-3′
LIN28-reverse 5′-GGAACCCTTCCATGTGCAG-3′.
We isolated the total RNA from the iPS cells using a 
High Pure RNA Isolation Kit (Roche Diagnostics GmbH, 
Roche Applied Science, Mannheim, Germany) according to 
the manufacturer’s protocol. First-strand cDNA were primed 
via random hexamers, which was carried out as described 
in the product protocol of the Transcriptor High Fidelity 
cDNA Synthesis Kit (Roche). PCR was then carried out with 
1 µL cDNA for one cycle of 94°C for 2 minutes followed 
by 30 cycles of 94°C for 30 seconds, 60°C for 30 seconds, 
and 72°C for 3 minutes using gene-specific primers and Taq 
polymerase. PCR productions were detected by 1% agarose 
gel electrophoresis with ethidium bromide.
Detection of human es cell 
surface-specific biomarkers by 
immunofluorescence staining  
and flow cytometry analysis
The iPS cells were fixed with 4% paraformaldehyde 
  (prepared freshly in PBS) for 20 minutes at room temperature 
and washed three times with PBS for 5 minutes each. Cells 
were blocked with 1% bovine serum albumin (BSA) and 
10% normal donkey serum in PBS (blocking buffer) at 
room temperature for 45 minutes. After blocking, cells were 
probed with anti-SSEA-3 (Chemicon, Temecula, CA, USA), 
anti-SSEA-4 (Chemicon), anti-Tra-1-60 (Chemicon), and 
anti-Tra-1-81 (Chemicon) primary antibody. Then, cells 
were washed three times with 2 mL of 1% BSA PBS for 
5 minutes each. After washing, cells were incubated with 
PE-goat-anti-rat (AbD serotec) and PE-goat-anti-mouse 
(Caltag) secondary antibody. Hoechst (Invitrogen) were used 
for counterstaining. Cells were then washed three times with 
PBS for 5 minutes each, and the plates were stored wrapped 
in aluminum foil at 4°C in 2 mL PBS until they could be 
visualized with a fluorescence microscope.
Adherent cells were individualized by trypsin   treatment 
(0.05% trypsin/0.5 mM EDTA, Invitrogen) and were 
  processed directly for antibody staining. The cells were 
filtered through a 40 µm mesh and resuspended in FACS 
buffer (PBS containing 2% FBS and 0.1% sodium azide). International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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About 100 µL of cell suspension containing 5 × 105 cells 
was used in each labeling. Both primary and secondary 
antibody incubation was carried out at room temperature 
for 30 minutes. After washing, the cells were resuspended in 
300–500 µL of the FACS buffer and proceeded for analysis 
on a BD FACSCalibur™ Flow Cytometer using CellQuest™ 
acquisition and analysis software. A total of 20,000 events 
were acquired.
embryoid body formation and in vitro 
differentiation into three germ layers
Expression of three germ layer differentiation markers was 
analyzed by quantitative RT-PCR. iPS cells were passaged 
five times, cell clumps were collected and washed four times 
with DMEM/F12, cell clumps were transferred to 6-well 
Low Attachment Culture Dishes (Corning®, NY, USA) with 
embryoid body (EB) medium change. EB formation was 
monitored by microscope. For quantitative gene expression 
analysis, EBs were collected at day 12, RNA was isolated 
using the High Pure RNA Isolation Kit (Roche), reverse 
transcription and real time PCR was performed using 
  Transcriptor High Fidelity cDNA Synthesis Kit (Roche) and 
ExTaq™ (Takara Bio Inc., Shiga, Japan). β-actin was used as 
a normalization control. Expression of TUBB3 (ectoderm), 
HAND1 (mesoderm), and FOXA2 (endoderm) markers was 
quantified against undifferentiated control iPS cells.
Karyotype analysis
The iPS cells were passaged eight times and treated with 
0.4 µg/mL colcemid for 2 hours at 37°C. The iPS cells 
were collected by 0.05% trypsin treatment and cocultured 
with the 0.5 mL 0.075 mol/L KCL in 37°C for 30 minutes, 
then swelled with glacial acetic acid and fixed with 2.5% 
  glutaraldehyde and finally stained with Gemsa. Karyotype 
analysis was performed at the same time.
Terotoma formation and he staining
The human iPS cells from the 100 mm dish grown on MEF 
feeder layers were harvested by collagenase IV treatment 
and collected into tubes and centrifuged, then suspended in 
100 µL human ES cell medium and injected subcutaneously 
to the dorsal flank of 6-week-old NOD-SCID mice. HDF cells 
were also injected as control. One to 2 months postinjection, 
tumors were typically observed and surgically dissected 
from the mice and fixed with 4% paraformaldehyde. Tumor 
samples were embedded in paraffin, cut into 20 µm sections, 
stained with hematoxylin and eosin, and examined by light 
microscopy.
Labeling iPs cells with FMNPs
FMNPs were synthesized and saved by our laboratory. The 
preparation and characterization of FMNPs were reported 
in our previous papers.25–27 The iPS cells were seeded on 
the cover slips and treated with growth medium containing 
FMNPs (50 µg/mL) for 4 hours at 37°C with 5% CO2. 
  Afterwards, the cells were rinsed with PBS and fixed with 
2.5% glutaraldehyde for 30 minutes. Finally, the samples were 
attached to glass plates using mounting medium and were 
observed under fluorescent microscope. Labeled iPS cells 
were digested by trypsin treatment (0.05% trypsin/0.5 mM 
EDTA, Invitrogen) and proceeded for analysis on a BD 
FACSCalibur Flow Cytometer using CellQuest acquisition 
and analysis software. A total of 20,000 events were acquired. 
We also used the magnetic resonance imaging (MRI) system 
to observe iPS cells labeled with FMNPs. The iPS cells were 
treated with 50 µg/mL FMNPs for 4 hours and were harvested 
by magnetic iron. Then, the labeled iPS cells were fixed with 
70% ethanol/PBS for 30 minutes on ice until imaging. MRI 
was performed using 3.0T field intensity by a GE HDX 3.0T 
MRI instrument equipped with GE Signa Excite 3.0T MRI 
software. The imaging protocol consisted of coronal and 
transverse T2-weighted spin echo (SE) pulse sequences. 
To produce T2 maps, the following imaging parameters 
were used: TR/TE = 1000/10, 20, 30, 40, 50, 60, 70, 80 ms; 
field of view = 8.0 cm; slice thickness = 2.0 mm; number of 
excitations = 2.
Statistical analysis
Each experiment was repeated three times in duplicate. 
The results were presented as mean ± standard deviation. 
Statistical differences were evaluated using the t-test and 
considered significant at P , 0.05.
Results
Identification of plasmids by enzyme 
digestion method
The pure vectors, including Oct4, Sox2, Nanog, LIN28, 
PMD2.G, and psPAX2, were extracted from the DH5α 
bacteria with lentivirus expression plasmids such as 
pSin4-EF2-Oct4-Pur, pSin4-EF2-Sox2-Pur, pSin4-EF2-
Nanog-Pur, pSin4-EF2-LIN28-Pur, enveloping plasmids 
PMD2.G, and packaging plasmid psPAX2. As shown 
in Figure S1   (supporting data), the six plasmids’ single-
site enzyme digestion results coincide with the dual-site 
enzyme   digestion results, which show that six plasmids 
were   successfully prepared.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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characterization of g5.0 dMNPs
The prepared dMNPs were characterized as shown in 
Figure S2 (supporting data). dMNPs were dispersed very 
well with an average diameter of 20–40 nm. The dendrimer 
modification process was proven by comparison of FT-IR 
spectra of the G5.0 dMNPs and MNPs. Compared with the 
MNP sample, the G5.0 dMNPs possess absorption bands 
at 2922 cm-1 and 2852 cm-1 due to the stretching vibration 
of the C–H bond, bands at 3422 cm-1 due to the bending 
vibration of the –NH2 group, and bands at 1719, 1637, 1560, 
and 1398 cm-1 due to the –CO–NH– group. All of those 
results proved the existence of dendrimer on the surface 
of MNPs.
Reprogramming hDF cells into iPs cells 
by dMNPs and lentivirus
293T cells were cultured to prepare four kinds of lentivi-
rus with Oct4, Sox2, Nanog, and LIN28 by using dMNPs 
as a transfection reagent. Compared with Lipofectamine 
2000, as shown in Figure 1, the titers of lentivruses 
based on dMNPs were 10-fold more than those based 
on Lipofectamine 2000. For example, the titers of Oct4 
virus were,   respectively, 1.5 × 1012 VP/mL for dMNPs, 
and 1.4 × 1011 VP/mL for   Lipofectamine 2000. Similarly, 
the results of the other three kinds of virus titer were also 
similar to Oct4. For example, the titers of Sox2 virus 
were 1.35 × 1012 VP/mL and 1.2 × 1011 VP/mL, the titers 
of Nanog virus,   respectively, were 1.6 × 1012 VP/mL and 
1.5 × 1011 VP/mL, and the titers of LIN28 virus, respec-
tively, were 1.55 × 1012 VP/mL and 1.3 × 1011 VP/mL 
based on dMNPs and Lipofectamine 2000 as transfection 
agents. Therefore, this proved that dMNPs could enhance 
the preparation efficiency of lentivirus with Oct4, Sox2, 
Nanog, or LIN28 genes. The   transfection efficiency of 
dMNPs was 10-fold more than that of   Lipofectamine 2000, 
which would provide more lentivirus for the following 
preparation of iPS cells.
The 293T cells’ supernatants were collected and 
concentrated after 48 hours of transfection for transduction 
usage. Figure 2A shows the primary cultured HDF cells. 
At 21 days after transduction, we observed iPS cell clones 
that look like ES cell clones, as shown in Figures 2B and 2C. 
The cells had a clear boundary, brighter large nucleoli, and 
scant cytoplasm, similar to human ES cells, as shown in 
Figure 2D. The cells exhibited positive staining for alkaline 
phosphatase, which suggests that the clone cells should be 
iPS cells.
Identification of iPS cells
To identify the iPS cells at the RNA level, we examined 
the expression levels of four genes by RT-PCR. As shown 
in Figure 2E, endogenous Oct4, Sox2, LIN28, and Nanog 
were reactivated and the exogenous transgenes were silenced, 
indicating that the pluripotent state was not maintained by 
continuous expression of exogenous factors. To   confirm the 
similarity of iPS cells and ES cells, we checked the expression 
levels of ES cell-specific biomarkers by fluorescent 
immunostaining and flow cytometry analysis. As shown 
in Figure 3A, the ES cell-specific surface markers, such as 
SSEA-3, SSEA-4, Tra-1-60, and Tra-1-81, exhibited positive 
expressions in the prepared iPS cells, but no positive staining 
was observed in the control HDF cells (data not shown). 
Figure 3B shows the flow cytometry expression analyses of 
human ES cell-specific markers in reprogrammed clones, 
which exhibited the prepared iPS cells highly expressed 
with SSEA-3, SSEA-4, Tra-1-60, and Tra-1-81. In addition, 
in order to demonstrate the pluripotency of iPS cells, we 
observed that the teratoma grew on the back of NOD-SCID 
mice, and HE staining results showed that the teratoma 
tissues were composed of three germ layers (endoderm, 
mesoderm, and ectoderm), as shown in Figure 4A, which 
fully demonstrates that the prepared iPS cells were able to 
differentiate into all three germ   layers evidenced by the neu-
ral ganglia, supporting cartilage, bone and smooth muscle, 
submucosa glands, and neural epithelium. Simultaneously, 
we also carried out karyotype analysis of iPS cells. The 
iPS cells had a normal karyotype. G-banding chromosome 
analysis is represented in Figure 4B. To further determine 
the pluripotency of iPS cells, EBs were formed after iPS 
cells were cultured in suspension for 7 days. Quantitative 
RT-PCR analysis was performed on 12-day-old EBs with 
expression of HAND1 (heart and neural crest derivatives 
expressed 1-mesoderm), TUBB3 (tubulin beta 3-ectoderm), 
dMNPs
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and FOX-A2 (forkhead box A2-endoderm), as shown in 
Figure 5. All these data fully demonstrate that the iPS cells 
were successfully prepared.
Labeling iPs cells with FMNPs
The prepared FMNPs were characterized as shown in 
Figure S3 (supporting data). TEM imaging exhibited that 
FMNPs were sphere with an average diameter of 100 nm. 
Figure S3 (B) shows the fluorescence of FMNPs under 
ultraviolet radiation. FMNPs were assembled and the 
solution became transparent under the external   magnetic 
field (left). After removal of the external magnetic field, 
the aggregations were rapidly redispersed evenly (right). 
  Figure S3 (C) shows a magnetic hysteresis curve of FMNPs. 
This clearly indicates that FMNPs   maintained super-
paramagnetic property at room temperature and reached 
a saturation magnetization (Ms) value of 4.0 emu g-1. 
The photoluminescence spectra of FMNPs are shown in 
Figure S3 (D). The emission peak of FMNPs remained 
symmetric.
After FMNPs were incubated with iPS cells for 4 hours, 
we observed that FMNPs entered the iPS cells. Figure 6A 
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Figure 2 generating iPs cells from hDF cells. A) The morphology of primary passage of human foreskin fibroblast (100X). B) Primary induced pluripotential stem cell 
colony (400X). C) iPS cells grown on irradiated MEFs (200X). D) Alkaline phosphatase staining of iPS cells (100X). E) The gene expression profiles of iPS cells by DNA 
electrophoresis.
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shows the morphology of iPS cells under a bright field. 
Figure 6B shows iPS cells with a strong red fluorescent 
signal under fluorescent microscopy, which suggests that 
FMNPs are located inside iPS cells. Figure 6C shows the 
flow cytometry analysis result of intracellular FMNPs. 
The iPS cells labeled with 50 µg/mL FMNPs expressed 
74% positive signals. In order to further confirm the iPS 
cells labeled with FMNPs, we used an MRI system to 
detect the magnetic signals of iPS cells. The labeled iPS 
cells and control iPS cells were, respectively, dispersed in 
70% ethanol/PBS fixed buffer in eppendorf tubes. Cells 
underwent MRI under 3.0T field intensity. T2-weighted 
images were obtained by adding together the different 
T2-weighted data during raw data acquisition, as shown 
in Figure 6D. The average magnetic resonance intensity 
of iPS cells labeled with FMNPs was 0.0650T, and the 
average magnetic resonance intensity of iPS cells not 
labeled with FMNPs was 0.00801T. This exhibited that 
the labeled iPS cells had stronger magnetic signals than 
control iPS cells.
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Discussion
Since the iPS cells were successfully produced, iPS cell 
research and development has become a hot topic. Although 
iPS cells exhibit an attractive application prospect in regen-
erative medicine, to date, how to obtain high-quality iPS cells 
is still a great challenge. So far, iPS cell in vivo distribution 
and development are still not clarified, which is due to the 
shortage of more efficient iPS cell-labeling technologies. 
However, using nanomaterials’ unique properties may help 
to solve current problems.
In this study, in order to obtain iPS cells efficiently, at 
first, we had to obtain enough lentivirus with Oct4, Sox2, 
LIN28, and Nanog. In our previous work, we found that G5.0 
PAMAM dMNPs with good biosafety can take a lot of genes 
and highly efficiently deliver genes into different kinds of 
cells. Thus, we finally selected G5.0 PAMAM dMNPs as a 
delivery system for four transcription factor genes, ie, Oct4, 
Sox2, LIN28, and Nanog, and packaging plasmids such as 
PSPAX2 and PMD2.G to enter into 293T cells. The results 
showed that G5.0 PAMAM dMNPs successfully deliver many 
vectors with Oct4, Sox2, LIN28, and Nanog genes into 293T 
cells. The titers of Oct4, Sox2, LIN28, and Nanog viruses 
produced by dMNPs were 10 times more than those based on 
Lipofectamine 2000. Thus, we consider that G5.0 PAMMAM 
dMNPs could enhance the preparation efficiency of lentivirus. 
This step is very important in order to prepare iPS cells that 
can provide enough lentivirus for further preparation of iPS 
cells within a limited timeframe. In the course of follow-up 
experiments, we collected and concentrated supernatant 
liquids with lentivirus from 293T cells and coincubated it 
with human fibroblast cells at 37°C for 21 days. Then, we 
obtained ES-like cells. We confirmed those ES-like cells were 
iPS cells by using RT-PCR, immunostaining analysis, and the 
terotomas formation test. Although the preparation efficiency 
of iPS cells produced from HDF cells is only associated with 
integration efficiency of lentivirus into cell genome, not asso-
ciated with lentivirus titer, high titer of lentivirus can transduct 
more HDF cells and produce more iPS cells, which is helpful 
and can save time. Therefore, we consider that preparation 
efficiency of iPS cells is indirectly enhanced.
Regarding potential mechanism, it is well known that 
dMNPs are one kind of nanocomposite with a positive charge 
that has excellent chemical structure and biocompatibility. 
As the generation of PAMAM dendrimers increased, the 
amount of plasmids absorbed by dMNPs also increased 
correspondingly. They were able to attach to the cell membrane 
surface via charge attraction and then induced nanoscale hole 
formation on the surface of cell membranes.28,29 They then 
took plasmids into cytoplasm highly efficiently. Because of 
the specific environment inside cells, exogenous vectors can 
be released from the dMNP–plasmid composites and enter 
the cell nucleus, producing a lot of virus plasmids, then 
interacting with the packaging plasmids, finally resulting 
in lentivirus virus formation and secretion into 293T cells’ 
supernatant. Because G5.0 PAMAM dMNPs can take 
more vectors into 293T cells than Lipofectamine 2000, the 
lentivirus titers based on dMNPs are higher than those based 
on Lipofectamine 2000.
In recent years, with the rapid progress of iPS cell 
research and development, how to prepare the labeled 
iPS cells for imaging and tracking in vivo has become an 
important question. Traditional labeling methods such as 
cytoplasm markers labeled with PKH26 and DIL, nucleic 
acid markers labeled with BrdU and DAPI, and gene markers 
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Figure 6 The images of induced pluripotent stem cells (iPS) labeled with fluorescent 
magnetic nanoparticles (FMNPs). A) The microscopy image of iPs cells labeled with 
FMNPs under bright light (200X). B) The fluorescent microscopy image of iPS cells 
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labeled with LacZ and GFP have different limitations. The 
biggest problem is how to track stem cells in vivo.30–32 In this 
study, with the aim of investigating the feasibility of labeling 
iPS cells for long-term tracing and imaging, we successfully 
labeled iPS cells with FMNPs. Our prepared FMNPs are 
silica-coated quantum dots and FMNPs, which have both 
fluorescent signals and magnetic signals and have good 
biocompatibility. Fluorescent signals can be used for iPS 
cell tracking and imaging, and magnetic signals can be used 
for iPS cell isolation and MRI imaging. When prepared iPS 
cells are incubated with FMNPs for 4 hours or overnight, we 
observed FMNPs located inside the iPS cells. We continued 
to culture the iPS cells for 1 month and observed fluorescent 
signals existing in iPS cells, which highly suggests that 
FMNPs in iPS cells were not easily exited.
To date, there are some molecular imaging technologies 
that can be used to track stem cells in vivo, such as 
  bioluminescence imaging (BLI), fluorescence imaging (FI), 
positron emission tomography (PET), single photon emission 
computed tomography (SPECT), and MRI.33–37 In this study, 
we used FI technology to observe iPS cells. The iPS cells 
exhibited red fluorescent signals. We also used MRI to 
image the collected iPS cells inside the eppendorf tubes. The 
labeled iPS cells exhibited higher magnetic intensity signals 
than the control iPS cells. Although the magnetic intensity 
difference between labeled iPS cells and control iPS cells 
was very small, the labeled iPS cells were attracted by an 
in vitro magnetic field and adhered to the tube wall (data not 
shown). Conversely, the control iPS cells could not stick to 
the tube wall. Therefore, we consider that the iPS cells were 
successfully labeled with FMNPs, which has laid the founda-
tion for further tracking and imaging in the near future.
In conclusion, human iPS cells can be efficiently 
generated from HDF by using the dMNPs and a lentivi-
rus system. dMNPs markedly enhanced the efficiency 
of lentivirus supernatants produced from 293T cells and 
indirectly enhanced the preparation efficiency of iPS cells. 
The prepared iPS cells were also successfully labeled with 
FMNPs, which lay the foundation for further isolating, in 
vivo imaging, and tracking of iPS cells in the near future. 
The established methods should be the first report. We 
believe that stem cell nanotechnology has great potential 
application in the research and development of stem cells 
in the near future.
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Figure  S2  Characterizations  of  dendrimer-modified  magnetic  nanoparticles 
(dMNPs). A) Transmission electron microscope image of dMNPs. B) The Fourier 
transform infrared spectra of dMNPs: a) MNPs, b) dMNPs.
Figure S1 The digestion maps of plasmid DNA. a) single-site digestion map of 
plasmids DNA. b) Double-site digestion map of plasmid DNA.
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Figure S3 Characterizations of fluorescent magnetic nanoparticles (FMNPs). A) The 
transmission electron microscope image of FMNPs. B) The fluorescent image of FMNPs 
with/without external magnetic field. C) The field-dependent magnetization curve of 
FMNPs at room temperature. D) The photoluminescence spectra of FMNPs.